Dissemination of class 1, 2 and 3 integrons among different multidrug resistant isolates of Acinetobacter baumannii in Tehran hospitals, Iran

• Autorzy: Taherikalani M. , Maleki A. , Sadeghifard N. , Mohammadzadeh D. , Soroush S. , Asadollahi P. , Asadollahi K. , Emaneini M.
• Języki publikacji: EN

Abstrakty

EN

A total of 100 non-duplicate Acinetobacter baumannii isolates were collected from different hospitals in Tehran and were confirmed as A. baumannii by conventional biochemical and API testing. Antimicrobial susceptibility of these isolates was checked by a disk diffusion method in accordance with CLSI guidelines. The isolates were then detected as carrying class 1 and 2 integron gene cassettes by PCR evaluation and then genotyped by REP-PCR. More than 50% (n = 50) of the isolates were multidrug resistant. The results showed that more than 80% of all multidrug resistant A. baumannii strains carry a class 1 integron. Distribution of IntI 1 and IntI2 among A. baumannii isolates was 58% and 14%, respectively. Analysis of a conserved segment of class 1 integron showed a range from 100 bp to 2.5 kb. REP-PCR fingerprinting showed more than 20 genotypes among A. baumannii strains. There was no relationship between REP genotypes and the distribution of different classes of integrons. This is a comprehensive study on the distribution of different classes of integrons among A. baumannii in Iran. Considering the exact role of integrons in coding drug resistance in bacteria, the findings of this study could help us find antimicrobial resistant mechanisms among A. baumannii isolates in Iran.

Słowa kluczowe

EN

dissemination; integron; multidrug resistance; isolate; Acinetobacter baumannii; Tehran; hospital; Iran

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2011
• Tom: 60
• Numer: 2
• Opis fizyczny: p.169-174,fig.,ref.

Twórcy

autor

Taherikalani M.

• Department of Medical Microbiology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran

autor

Maleki A.

autor

Sadeghifard N.

autor

Mohammadzadeh D.

autor

Soroush S.

autor

Asadollahi P.

autor

Asadollahi K.

autor

Emaneini M.

Bibliografia

• Akbari M., M. Niakan, M. Teherikalani, M.M. Feizabadi, N.A. Azadi, S. Soroush, M. Emaneini, A. Abdolkarimi, A. Maleki and A. Hematian. 2010. Rapid identification of Iranian Acinetobacter baumannii strains by single PCR assay using bla OXA-51-like carbenemase and evaluation of the antimicrobial resistance profiles of the isolates. Acta Microbiol. Immunol. Hung. 57: 87–94.
• Bou, G., G. Cervero, M.A. Dominguez, C. Quereda and J. Martinezeltran. 2006. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin. Microbiol. Infect. 6: 635–643.
• Clinical and Laboratory Standard Institute. 2006. Performance Standards for Antimicrobial Disk Susceptibility tests; 9th for informational Supplement, M2-A9.Clinical and Laboratory Standards Institute, Wayne, Pa.
• von Dolinger de Brito D., E.J. Oliveira, V.O. Abdallah, A.L. da Costa Darini and P.P. Filho. 2005. An outbreak of Acinetobacter baumannii septicemia in a neonatal intensive care unit of a university hospital in Brazil. Braz. J. Infect. Dis. 9: 301–309.
• Fontana C, M. Favaro, S. Minelli, M.C. Bossa, G.P. Testore, F. Leonardis, S. Natoli and C. Favalli. 2008. Acinetobacter baumannii in intensive care unit: a novel system to study clonal relationship among the isolates. BMC Infect. Dis. 8: 79.
• Feizabadi M.M., B. Fathollahzadeh, M. Taherikalani, M. Rasoolinejad, N. Sadeghifard, M. Aligholi, S. Soroush and S. Mohammadiegane. 2008. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Jpn. J. Infect. Dis. 61: 274–278.
• Gallego L. and K.J. Towner. 2001. Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. J. Med. Microbiol. 50: 71–77.
• Gonzalez G., K. Sossa, H. Bello, M. Dominguez, S. Mella and R. Zemelman. 1998. Presence of integrons in isolates of different biotypes of Acinetobacter baumannii from Chilean hospitals. FEMS. Microbiol. Lett. 161: 125–128.
• Gombac F., M.L. Riccio, G.M. Rossolini, C. Lagatolla, E. Tonin, C. Monti-Bragadin, A. Lavenia and L. Dolzani. 2002. Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays. Antimicrob. Agents. Chemother. 46: 3665–3668.
• Koeleman J.G, M.W. van der Bijl, J. Stoof, C.M. Vandenbroucke-Grauls and P.H. Savelkoul. 2001. Antibiotic resistance is a major risk factor for epidemic behavior of Acinetobacter baumannii. Infect. Control. Hosp. Epidemiol. 22: 284–288.
• Navia M.M., J. Ruiz and J. Vila. 2002. Characterization of an integron carrying a new class D beta-lactamase (OXA-37) in Acinetobacter baumannii. Microb. Drug. Resist. 8: 261–265.
• Nemec A., L. Dolzani, S. Brisse, P. van den Broek and L. Dijkshoorn. 2004. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of panEuropean Acinetobacter baumannii clones. J. Med. Microbiol. 53: 1233–1240.
• Peleg A.Y, H. Seifert and D.L. Paterson. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21: 538–582.
• Ploy M.C, F. Denis, P. Courvalin and T. Lambert. 2000. Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron. Antimicrob. Agents. Chemother. 44: 2684–2688.
• Sallen B., A. Rajoharison, S. Desvarenne ans C. Mabilat. 1995. Molecular epidemiology of integron-associated antibiotic resistance genes in clinical isolates of enterobacteriaceae. Microb. Drug. Resist. 1: 195–202.
• Seward R.J. 1999. Detection of integrons in worldwide nosocomial isolates of Acinetobacter spp. Clin. Microbiol. Infect. 5: 308–318.
• Srinivasan V.B, G. Rajamohan, P. Pancholi, K. Stevenson, D. Tadesse, P. Patchanee, M. Marcon and W.A. Gebreyes. 2009. Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA. Ann. Clin. Microbiol. Antimicrob. 8: 21.
• Turton J.F, M.E. Kaufmann, J. Glover, J.M. Coelho, M. Warner, R. Pike and T.L. Pitt. 2005. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J. Clin. Microbiol. 43: 3074–3082.
• Taherikalani M., B. Fatolahzadeh, M. Emaneini, S. Soroush and M.M. Feizabadi. 2009. Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals. New Microbiol. 32: 265–271.
• Taherikalani M., G. Etemadi, K.N. Geliani, B. Fatollahzadeh, S. Soroush and M.M. Feizabadi. 2008. Emergence of multi and pan-drug resistance Acinetobacter baumannii carrying blaOXA-type-carbapenemase genes among burn patients in Tehran, Iran. Saudi. Med. J. 29: 623–624.
• Wang H., P. Guo, H. Sun, H. Wang, Q. Yang, M. Chen, Y. Xu and Y. Zhu. 2007. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob. Agents. Chemother. 51: 4022–4028.
• Zarrilli R., M. Crispino, M. Bagattini, E. Barretta, A. Di Popolo, M. Triassi and P. Villari. 2004. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J. Clin. Microbiol. 42: 946–953.